MyBlueDotsAspect Biosystems Raises US$115 Million Series B Financing to Advance Bioprinted Tissue Therapeutics MyBlueDots4 months ago01 mins VANCOUVER, British Columbia–(BUSINESS WIRE)– #biotech–Aspect Biosystems secures $115M Series B to advance bioprinted tissue therapeutics, accelerating development of functional cures for serious diseases Post navigation Previous: Resumen: Biocytogen y Acepodia combinan fuerzas para desarrollar anticuerpos biespecíficos y ADC de carga doble para el tratamiento de tumores complejosNext: NorthStar Medical Radioisotopes and YAP Therapeutics Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Products
An overlooked cell type orchestrates brain rewiring during states of heightened attention MyBlueDots3 days ago 0
Violence between parents or in the community increases risk of child punishment MyBlueDots3 days ago 0
Genome mapping of Brazil’s diverse population uncovers new variants linked to health MyBlueDots3 days ago 0